SIRT1 has been linked to immune-related diseases such as tumors and autoimmune diseases (Yu et al., 2018) and was decreased in the PBMCs of multiple sclerosis patients during relapses (Martin et al., 2015). Here, SIRT1 is linked to multiple sclerosis.